Terms of Service: Enterprise
Last updated: 1 January 2026. These Enterprise Terms of Service (“Terms”) govern the use of ClinixSummary by organisations, health systems and enterprise accounts.
1. Definitions
“Customer” means the organisation or entity that enters into an Enterprise Agreement with GATMEDI Ltd. “Authorised Users” means the individuals within the Customer’s organisation who are permitted to access and use ClinixSummary under the Enterprise Agreement. “Platform” means the ClinixSummary AI clinical documentation system and all associated tools, APIs and interfaces.
2. Licence & Access
Subject to these Terms and payment of applicable fees, GATMEDI grants Customer a non-exclusive, non-transferable, revocable licence to access and use the Platform for the Customer’s internal clinical documentation purposes. Customer may provision Authorised Users up to the number specified in the Enterprise Agreement.
3. Enterprise Features
Enterprise accounts include: custom credit volumes; Billing Assistance module access; dedicated success manager; custom integration support (API, FHIR, HL7); team management and role-based access controls; organisation-level analytics dashboard; priority support with SLA guarantees; and custom BAA execution.
4. Data Ownership & Processing
Customer retains all rights, title and interest in its clinical data, transcripts and generated documentation. GATMEDI processes Customer data solely for the purpose of providing the Platform. GATMEDI does not use Customer data for model training. A Data Processing Agreement (DPA) and Business Associate Agreement (BAA) are executed as part of every Enterprise Agreement.
5. Service Level Agreement
GATMEDI commits to a platform availability target of 99.9% uptime measured monthly, excluding scheduled maintenance windows. Scheduled maintenance is communicated at least 72 hours in advance. In the event of a service-level breach, Customer may be eligible for service credits as specified in the Enterprise Agreement.
6. Security & Compliance
GATMEDI maintains administrative, physical and technical safeguards consistent with industry standards including: AES-256 encryption at rest; TLS 1.2+ in transit; SOC 2-aligned processes; annual penetration testing; role-based access controls; comprehensive audit logging; and HIPAA, GDPR, PIPEDA/PHIPA, and CCPA compliance. Security documentation and audit reports are available upon request under NDA.
7. Fees & Payment
Enterprise fees are set out in the Enterprise Agreement and may be based on: per-user licensing, credit volume, or custom pricing structures. Invoices are issued monthly or annually as agreed. Payment is due within 30 days of invoice date. Late payments may incur interest at the lesser of 1.5% per month or the maximum rate permitted by law.
8. Term & Termination
Enterprise Agreements run for the initial term specified in the Agreement and renew automatically for successive 12-month periods unless either party provides 90 days’ written notice of non-renewal. Either party may terminate for material breach if the breach remains uncured 30 days after written notice. Upon termination, Customer may export all data within 60 days, after which data is permanently erased.
9. Limitation of Liability
ClinixSummary is a documentation assistance tool. All generated content requires clinician review and approval before clinical use. GATMEDI shall not be liable for clinical decisions made based on platform outputs. GATMEDI’s total aggregate liability shall not exceed the fees paid by Customer in the 12 months preceding the claim. Neither party shall be liable for indirect, consequential, incidental or punitive damages.
10. Intellectual Property
GATMEDI retains all intellectual property rights in the Platform, including algorithms, models, interfaces and documentation. Customer retains all rights in its clinical data. Neither party acquires any rights in the other party’s intellectual property except as expressly granted in these Terms.
11. Governing Law
These Terms are governed by the laws of England and Wales. Disputes shall be resolved through good-faith negotiation, followed by mediation and, if necessary, binding arbitration under the rules of the London Court of International Arbitration. For Enterprise customers, jurisdiction may be modified by mutual agreement in the Enterprise Agreement.
Ready to discuss Enterprise terms?
Our team can walk you through licensing, compliance requirements and custom agreements.
Contact Enterprise Sales